Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the domain of hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and manipulation are altering the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative appr